Cargando…

Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer

SIMPLE SUMMARY: Serous endometrial cancer is an unusual and aggressive endometrial cancer subtype, conferring the highest mortality of all endometrial cancers. In many ways, it resembles the more common tumor entity high-grade serous ovarian cancer. Thus, there is an urgent need for better treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jönsson, Jenny-Maria, Bååth, Maria, Björnheden, Ida, Sahin, Irem Durmaz, Måsbäck, Anna, Hedenfalk, Ingrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827019/ https://www.ncbi.nlm.nih.gov/pubmed/33445465 http://dx.doi.org/10.3390/cancers13020254

Ejemplares similares

Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
por: Sahin, Irem Durmaz, et al.
Publicado: (2019)

MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
por: Bååth, Maria, et al.
Publicado: (2021)

Molecular Subtyping of Serous Ovarian Tumors Reveals Multiple Connections to Intrinsic Breast Cancer Subtypes
por: Jönsson, Jenny-Maria, et al.
Publicado: (2014)

SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
por: Bååth, Maria, et al.
Publicado: (2020)

Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival()()
por: Jönsson, Jenny-Maria, et al.
Publicado: (2015)

Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response
por: Martín de la Fuente, Laura, et al.
Publicado: (2018)

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
por: Martin de la Fuente, Laura, et al.
Publicado: (2020)

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma
por: Arildsen, Nicolai Skovbjerg, et al.
Publicado: (2017)

Prevalence and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in Uterine Serous Carcinoma
por: Dong, Lin, et al.
Publicado: (2022)

Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes
por: Sohn, Min-Hwan, et al.
Publicado: (2021)

Identifying and Overcoming Mechanisms of PARP Inhibitor Resistance in Homologous Recombination Repair-Deficient and Repair-Proficient High Grade Serous Ovarian Cancer Cells
por: Gomez, Miriam K., et al.
Publicado: (2020)

Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors
por: Lee, Minyi, et al.
Publicado: (2020)

Analysis of repair mechanism choice during homologous recombination
por: Agmon, Neta, et al.
Publicado: (2009)

Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
por: Choi, Min Chul, et al.
Publicado: (2020)

CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors
por: Lu, Xue, et al.
Publicado: (2022)

TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer
por: Chien, Jeremy, et al.
Publicado: (2015)

Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients
por: Feng, Zheng, et al.
Publicado: (2021)

A Benchmark of In-House Homologous Recombination Repair Deficiency Testing Solutions for High-Grade Serous Ovarian Cancer Diagnosis
por: Guarischi-Sousa, Rodrigo, et al.
Publicado: (2023)

OTUB2 Promotes Homologous Recombination Repair Through Stimulating Rad51 Expression in Endometrial Cancer
por: Wan, Qiuyuan, et al.
Publicado: (2020)

Development of Serous Ovarian Cancer is Associated with the Expression of Homologous Recombination Pathway Proteins
por: Ye, Qingqing, et al.
Publicado: (2014)

Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer
por: Bouberhan, Sara, et al.
Publicado: (2020)

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma
por: Takaya, Hisamitsu, et al.
Publicado: (2020)

Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
por: Arildsen, Nicolai Skovbjerg, et al.
Publicado: (2019)

Homologous Recombination Repair Polymorphisms and the Risk for Osteosarcoma
por: Goričar, Katja, et al.
Publicado: (2015)

Leveraging homologous recombination repair deficiency in sarcoma
por: Slade, Dea, et al.
Publicado: (2023)

Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
por: Patel, Jai N., et al.
Publicado: (2018)

Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma
por: Shi, Zhiwen, et al.
Publicado: (2021)

DEK is required for homologous recombination repair of DNA breaks
por: Smith, Eric A., et al.
Publicado: (2017)

Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity
por: van Wilpe, Sandra, et al.
Publicado: (2021)

A plant-specific module for homologous recombination repair
por: Wang, Xuanpeng, et al.
Publicado: (2022)

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair
por: Sanchez-Bailon, Maria Pilar, et al.
Publicado: (2021)

Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma
por: Pitiyarachchi, Omali, et al.
Publicado: (2023)

Mechanism of RBBP8‐mediated homologous recombination repair in gastric cancer synthetic lethal
por: Yu, Yang, et al.
Publicado: (2023)

C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2021)

Metastatic serous endometrial carcinoma to the ureter
por: Sahl, Jessa W., et al.
Publicado: (2021)

Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System
por: Wiedemeyer, W. Ruprecht, et al.
Publicado: (2014)

Repair of gaps opposite lesions by homologous recombination in mammalian cells
por: Adar, Sheera, et al.
Publicado: (2009)

REV1 and polymerase ζ facilitate homologous recombination repair
por: Sharma, Shilpy, et al.
Publicado: (2012)

Regulators of homologous recombination repair as novel targets for cancer treatment
por: Krajewska, Małgorzata, et al.
Publicado: (2015)

Genome-wide Transcriptome Profiling of Homologous Recombination DNA Repair
por: Peng, Guang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_btqjjan1umsggt8jn14526o9t6